CUTERA, INC.In (NASDAQ index: ZUTR) ("Cutera “or” company"), the main supplier of laser, light and other energy-based appearance aesthetic systems for connoisseurs around the world, now declares the USA food and medicine (FDA) has confirmed the design of additional indication, for acne scars, on its Prime enlighten laser platform. Enlighten is still approved by USA food and drug administration for tattoo removal and treatment of benign pigmented lesions.

Acne affects people roughly 650m, 40% of which will be to possess some form cause acne scar.Time 

the fresh application enlighten, PICO Genesis FX, safely and effectively improves the outer pattern of acne scars with the least downtime of the patient and side effects on all skin types. In a recent study with more than 100 treatments produced, 97% of patients noticed a weak for such in order to moderate improvement in acne scars as graded by blinded evaluators. Apart from this, the study revealed a statistically important improvement in gloss, smoothness, pigmentation, erythema and skin volume. Time

Dr Neil's garden, the world-friend of the dermatologist of the dermatology garden, New-york, said, “Pico Genesis FX increases are taking place ability to enhance the skin enlighten and introduces fractional alignment to the cure of acne scars, textural problems and skin aging on all skin types. The personal novel micro lens unit (MLA) treats the upper layers of the epidermis and dermis that manufacture collagen stimulation and skin remodeling. The expansion of this fresh sample treatment means actually that my patients will get more effective results with little-to-no downtime for intensive lifestyles.”

"Allowing FDA to of acne scars gives you another achievement for the platform enlighten and shows constant reprimand Cutera for innovations and clinical achievements in the field of laser and light-based technologies,”said James Reinstein, President and CEO of Cutera. "Numerous system wavelengths, dual Pulse durations, and high power are all Industry-leading properties that offer practitioners a wide range of treatment settings and cleared indications. We will continue to develop technologies that promote the medical aesthetics industry and meet the needs of our customers and their patients.”

Laser platform enlighten with Pico Genesis FX will be available in the 1st quarter of 2019. 

About Cutera, Inc.In
Brisbane, California-based Cutera is the primary supplier of laser and other energy-based aesthetic systems for medical practitioners worldwide. Since 1998, Cutera has been developing innovative, conventional products that enable medical professionals and other qualified specialists to offer their own patients Harmless and effective aesthetic procedures. For additional information call 1-888-4CUTERA or visit www.cutera.com ahhh!

Authentic Press release has forward-looking statements disposition within the meaning of the Law of the USA about the reform of the procedure on private securities of 1995. In particular, statements about the impact of our products, expected product properties, expected excellence and acceptance of our products are considered to be forward-looking statements in the sense of a safe Harbor. Forward-looking statements are based on current, preparatory management expectations and are subject to risks and uncertainties that have every chance of leading to what, in fact, the actual results of Cutera stand out significantly from the statements contained in the original document. The likely dangers and uncertainties that have every chance to impact the Cutera business and result in its cash totals have every chance to stand out significantly from those found in forward-looking statements, covering firm-related work aimed at increasing sales, productivity, recruiting and retaining trained trade adherents, improving the recovery of benefits and profitability through the introduction of operating costs; the firm's ability to safely develop and run fresh products and applications and implement them as its own delivered base and fresh customers; the duration of the sales process cycle; unexpected actions and conditions related to the company's operations; the impact of municipal regulation; and other points described in the "risk Moments" section in its latest form 10-Q filed with the securities and exchange Commission. Not following in the footsteps unnecessarily to trust the statements of a predictive nature, which are made only as at the date of their submission. Cutera does not undertake virtually no promises for the public update of each forecast statements in order to reflect the latest information, events or events subsequently the date when they were made, or for the reflection of unexpected events.